OverviewChartNewsTraderScreen

Wuxi Biologics (Cayman)/  US98260N1081  /

Nasdaq Other OTC
2024-04-18  9:59:51 PM Chg. 0.0000 Volume Bid- Ask- High Low
3.3300USD 0.00% 214,163
Turnover: 704,731.5999		 -Bid Size: - -Ask Size: - 3.3600 3.3175
GlobeNewswire 2023-11-21 Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics
GlobeNewswire 2023-10-31 Immutep Quarterly Activities Report Q1 FY24
GlobeNewswire 2023-09-21 Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Tria...
TeleTrader 2022-10-07 US Commerce Dept adds 31 Chinese firms to 'unverified list'
GlobeNewswire 2021-03-23 AC Immune Reports Full-Year 2020 Financial Results and Provides 2021 R&D Outlook
GlobeNewswire 2021-03-23 Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Deve...
GlobeNewswire 2021-01-22 Immutep Quarterly Activities Report
GlobeNewswire 2021-01-19 Oxford BioTherapeutics Designates Second Bispecific Antibody Program Leveraging WuXi Biologics’ WuXi...
GlobeNewswire 2020-12-16 Immutep Upscales Efti Manufacturing
GlobeNewswire 2020-11-13 AC Immune Reports Q3 2020 Financial Results and Provides Business Update
GlobeNewswire 2020-11-09 AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 ...
GlobeNewswire 2020-10-29 AB2 Bio and WuXi Biologics Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Ta...
GlobeNewswire 2020-08-11 Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
GlobeNewswire 2020-05-29 Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential CO...
GlobeNewswire 2020-05-12 Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
GlobeNewswire 2020-05-07 Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
GlobeNewswire 2020-05-06 Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates
GlobeNewswire 2020-04-30 Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific An...
GlobeNewswire 2020-03-26 Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial ...
GlobeNewswire 2020-03-25 Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19
GlobeNewswire 2020-03-02 Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates
GlobeNewswire 2020-02-25 Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to ...
GlobeNewswire 2020-01-13 Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
GlobeNewswire 2020-01-07 Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-G...
GlobeNewswire 2019-10-28 Operational Update